Previous 10 | Next 10 |
home / stock / opssf / opssf news
OPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES Canada NewsWire Conference call will be held today at 11:00 a.m. ET QUEBEC CITY , July 14, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company"...
OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III Canada NewsWire QUEBEC CITY , July 11, 2022 /CNW/ - OpSens Inc. . ("OpSens" or the "Company") (TSX:OPS) (OTCQX:OPSSF), a medical device cardiolog...
OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14 Canada NewsWire Conference call to be conducted at 11:00 am ET QUEBEC CITY, QC , July 7, 2022 /CNW Telbec/ - OpSens Inc. ("O...
OPSENS ANNOUNCES GLOBAL SAVVYWIRE™ FIRST COMMERCIAL USE Canada NewsWire Dr. Josep Rodés-Cabau at the Quebec Heart and Lung Institute – Laval University and Dr. Réda Ibrahim at The Montreal Heart Institute performed the first utilization simu...
OPSENS SAVVYWIRE™ FIRST-IN-HUMAN RESULTS PRESENTED AT EUROPCR IN PARIS AND SIMULTANEOUSLY PUBLISHED IN EUROINTERVENTION JOURNAL Canada NewsWire QUEBEC CITY , May 19, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (O...
OPSENS ANNOUNCES PUBLICATION IN JSCAI OF DATA SUPPORTING THE CORRELATION BETWEEN THE OPTOWIRE AND A NOVEL TAVR INTERFACE WITH STANDARD OF CARE, BEFORE AND AFTER TAVR Canada NewsWire QUEBEC CITY , May 18, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the ...
OPSENS ANNOUNCES HEALTH CANADA APPROVAL FOR ITS NEW TAVR GUIDEWIRE Canada NewsWire QUEBEC CITY , April 26, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company deliveri...
The following slide deck was published by Opsens Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Opsens Inc. 2022 Q1 - Results - Earnings Call Presentation
Opsens Inc. (OPSSF) Q2 2022 Earnings Conference Call April 13, 2022, 11:00 AM ET Company Participants Robert Blum - Lytham Partners, IR Louis Laflamme - President and CEO Robin Villeneuve - Chief Financial Officer Conference Call Participants Rahul Sarugaser - Raymond James Justin Keywood - S...
Opsens press release (OTCQX:OPSSF): Q2 GAAP EPS of -C$0.02. Revenue of C$8.1M (-8.0% Y/Y). For further details see: Opsens GAAP EPS of -C$0.02, revenue of C$8.1M
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated (ONCSQ) is expected to report for quarter end 2023-10-31 Educational Development Corporation (EDUC) is expected to report for Q3 2024 Solitron Devices, Inc. (SODI) is expected to report for Q3 2024 Loop Industries Inc. (LOOP) is expected to report $-0.07 f...
Opsens Inc (OPSSF) is expected to report $-0.01 for Q1 2024
HAEMONETICS COMPLETES ACQUISITION OF OPSENS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Dec. 12, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) , a medical...